Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03295279 · ClinicalTrials.gov registry record
WTC Chest CT Imaging Archive
A clinical trial of Lung Cancer and Interstitial Lung Disease, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 2,122
- Enrollment target
- 1
- Study location
NCT03295279: Recruiting study of Lung Cancer and Interstitial Lung Disease, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03295279 is a study of Lung Cancer and Interstitial Lung Disease that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2,122 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03295279, a study of Lung Cancer and Interstitial Lung Disease, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 2,122 participants
- Enrollment target
- 1
- Study location
Study Summary
Dr. Rafael E de la Hoz and colleagues have performed standardized and computer-assisted readings of all chest CT scans received by WTC workers and volunteers at the Mount Sinai Medical Center between 2003 and 2016. The clinical team sought to assess all findings suggestive of airway, interstitial, and neoplastic disease in a systematic way, and correlate those findings with clinical, functional, and exposure indicators. The study team's research will also involve analyses of longitudinal imaging and functional trends, and characterization of the WTC related lower airway diseases and their risk factors, with a focus on obesity-related imaging markers. The study team also plans to characterize the transitions into chronic obstructive pulmonary disease (COPD) among these workers. The researchers also propose to test the use of added respiratory surveillance tools and explore functional markers of disease progression, explore alternate methods to investigate longitudinal functional trajectories, and novel spirometry calibration methods that might facilitate the implementation of spirometry in nonspecialized settings.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,122 participants |
| Start Date | 2012-09-01 |
| Est. Completion | 2026-08 |
What NCT03295279 shows while recruiting
NCT03295279 is an observational study that tracks outcomes without assigning an intervention. Its 2,122 participants enrollment target places it among the larger protocols in the corpus, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (128% higher).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03295279 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03295279 about?
NCT03295279 is a clinical study titled "WTC Chest CT Imaging Archive". Dr. Rafael E de la Hoz and colleagues have performed standardized and computer-assisted readings of all chest CT scans received by WTC workers and volunteers at the Mount Sinai Medical Center between 2003 and 2016. The clinical team sought to assess all findings suggestive of airway, interstitial, a...
What is the current status of trial NCT03295279?
This trial is currently recruiting. The enrollment target is 2,122 participants. The study started on 2012-09-01. Estimated completion is 2026-08.
What conditions does trial NCT03295279 study?
This clinical trial studies the following conditions: Lung Cancer, Interstitial Lung Disease, Chronic Airway Disease.
Who is sponsoring clinical trial NCT03295279?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03295279 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03295279's enrollment target sits among peer trials
2,122 26th of 409 higher than 384 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI